NCT04788238 is a NA clinical trial of Dual-Task Zumba Gold in Mild Cognitive Impairment, sponsored by The Hong Kong Polytechnic University.

Who is sponsoring NCT04788238?

NCT04788238 is sponsored by The Hong Kong Polytechnic University.

What drugs are being tested in NCT04788238?

Interventions in NCT04788238: Dual-Task Zumba Gold.

What condition does NCT04788238 study?

NCT04788238 studies Mild Cognitive Impairment.

Is NCT04788238 still recruiting?

NCT04788238 is currently status unknown. Last updated 4 February 2022.

Last reviewed 2022-02-04 · How we verify

NCT04788238

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dual-Task Zumba Gold for Improving the Cognition of Older Adults With MCI

Status unknown NA Last updated 4 February 2022

What this trial tests

NA trial testing Dual-Task Zumba Gold in Mild Cognitive Impairment in 60 participants. Status unknown.

Timeline

29 March 2021

Primary endpoint
15 October 2021

31 August 2022

Quick facts

Lead sponsor	The Hong Kong Polytechnic University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	60
Start date	29 March 2021
Primary completion	15 October 2021
Estimated completion	31 August 2022
Sites	1 location across Philippines

Drugs / interventions tested

Dual-Task Zumba Gold

Conditions studied

Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 55 to 80, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to assess the preliminary efficacy of a Dual-Task Zumba Gold (DTZ) intervention that will support physical and cognitive training among community-dwelling persons with mild cognitive impairment (MCI). A 12-week Dual-Task Zumba Gold (DTZ) intervention will be implemented among 30 participants with MCI in the treatment group, while health education will be provided to another 30 subjects allocated in the control group. Changes in global cognitive function, together with the quality of life, mood, functional mobility, and bodily measures, will be re-assessed after the 12-week intervention and a 6-week follow-up period. Quantitative and qualitative methods will also be employed to assess the feasibility and acceptability outcomes of the study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Dual-Task Zumba Gold for Improving the Cognition of People With Mild Cognitive Impairment: A Pilot Randomized Controlled Trial.
Parial LL, Kor PPK, Sumile EF, Leung AYM. · · 2023 · cited 14× · PMID 35679826 · DOI 10.1093/geront/gnac081

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

NCT07505732 — Information-providing Chatbot · NA · not yet recruiting
NCT07391449 — Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis · NA · not yet recruiting
NCT07450248 — The Use of Telephone-based ACT for Quitting Alcohol in the Young Population With Hazardous or Harmful Alcohol Use. · NA · not yet recruiting
NCT07273682 — Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors · NA · not yet recruiting
NCT07531082 — Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coher · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04788238 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Hong Kong Polytechnic University
Last refreshed: 4 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04788238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing